{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:07:32Z","timestamp":1789106852394,"version":"build-2803163510"},"reference-count":88,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>While genetic abnormalities underlying lymphoid malignancies (LM) are well-characterized, the environmental and metabolic determinants driving LM remain largely unexplored. Autoimmune diseases are known risks, yet the specific circulating mediators and potential protective dietary factors linking these conditions to LM require systematic elucidation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to comprehensively screen for causal risk factors of LM, identify the metabolic mediators bridging autoimmune diseases and LM, and validate the therapeutic potential of leucine as a protective factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a systematic Mendelian randomization analysis using 10,090 GWAS traits obtained from the IEU OpenGWAS project, including 2,568 plasma proteins and 662 plasma metabolites, to identify potential causal determinants of LM. Findings were validated using the large-scale UK Biobank cohort (n=502,175) and further supported by multi-omics data (plasma proteomics (Olink; n = 53,014) and metabolomics (NMR; 486,813)) within the same population. Mechanisms were further verified via\n                      <jats:italic>in vitro<\/jats:italic>\n                      assays on LM cell lines and\n                      <jats:italic>in vivo<\/jats:italic>\n                      experiments using a MH\/NRASG12D B-cell precursor acute lymphoblastic leukemia (BCP-ALL) mouse model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified autoimmune diseases-specifically hyperthyroidism and membranous nephropathy, as novel risk factors for LM. Mediation analysis revealed that promotilin, monounsaturated fatty acids (MUFAs), and glucose serves as key circulating mediators driving this risk. Conversely, leucine emerged as a protective metabolic factor. High-leucine conditions suppressed proliferation and induced apoptosis in LM cell lines, while dietary leucine supplementation prolonged survival and alleviated anemia and thrombocytopenia in the BCP-ALL mouse models. In patient cohorts, higher plasma leucine levels were associated with improved outcomes in non-Ph B-ALL and prolonged survival in CAR-T-treated B-cell lymphoma patients. Mechanistically, leucine exposure induced metabolic reprogramming characterized by the suppression of lipid biosynthesis pathways and reduced\n                      <jats:italic>SREBF1\/FASN<\/jats:italic>\n                      -mediated\n                      <jats:italic>de novo<\/jats:italic>\n                      lipogenesis; pharmacological\n                      <jats:italic>FASN<\/jats:italic>\n                      inhibition recapitulated the anti-tumor effects of leucine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Autoimmune diseases increase LM susceptibility through specific metabolic mediators. Leucine functions as a potent protective agent and prognostic biomarker. These findings suggest that dietary leucine supplementation represents a promising and readily translatable therapeutic strategy for managing LM and enhancing CAR-T therapy efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1934057","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:30:12Z","timestamp":1789104612000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Leucine, autoimmune diseases, and circulating mediators shape the causal landscape of lymphoid malignancies"],"prefix":"10.3389","volume":"17","author":[{"given":"Dongguo","family":"Liang","sequence":"first","affiliation":[{"name":"Shanghai Institute of Hematology, National Research Center for Translational Medicine, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ren","sequence":"additional","affiliation":[{"name":"Shanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University","place":["Nanjing, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn","place":["Bonn, NRW, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo G.H.","family":"Schmidt-Wolf","sequence":"additional","affiliation":[{"name":"Department of Integrated Oncology, Center for Integrated Oncology (CIO) Bonn, University Hospital Bonn","place":["Bonn, NRW, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Renji Hospital, Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B3","first-page":"451","article-title":"Global cancer statistics 2022: The trends projection analysis","volume":"10","author":"Chhikara","year":"2023","journal-title":"Chem Biol Lett"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017715","article-title":"DDX41-associated susceptibility to myeloid neoplasms","volume":"141","author":"Makishima","year":"2023","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019425","article-title":"The clinical picture of ERCC6L2 disease: From bone marrow failure to acute leukemia","volume":"141","author":"Hakkarainen","year":"2023","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2141.2006.06337.x","article-title":"Down syndrome and acute lymphoblastic leukaemia","volume":"135","author":"Whitlock","year":"2006","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01495","article-title":"Cancer in children with Fanconi anemia and ataxia-telangiectasia-a nationwide register-based cohort study in Germany","volume":"40","author":"Dutzmann","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1182\/blood.2019001407","article-title":"Li-Fraumeni syndrome presenting as precursor B lymphoblastic leukemia mimicking intravascular large B-cell lymphoma","volume":"134","author":"Khatri","year":"2019","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s2542-5196(21)00149-2","article-title":"Benzene exposure and non-Hodgkin lymphoma: A systematic review and meta-analysis of human studies","volume":"5","author":"Rana","year":"2021","journal-title":"Lancet Planet Heath"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.5625","article-title":"Association of chemotherapy for solid tumors with development of therapy-related myelodysplastic syndrome or acute myeloid leukemia in the modern era","volume":"5","author":"Morton","year":"2019","journal-title":"JAMA Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol Off J Eur Soc For Med Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): Explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ (Clinical Res Ed)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(23)00348-0","article-title":"Mendelian randomisation at 20 years: How can it avoid hubris, while achieving more","volume":"12","author":"Smith","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1171446","article-title":"The causal effect of inflammatory bowel disease on diffuse large B-cell lymphoma: Two-sample mendelian randomization study","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.3390\/ijms24087216","article-title":"Celiac disease is a risk factor for mature T and NK cell lymphoma: A mendelian randomization study","volume":"24","author":"Mart\u00edn-Masot","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13075-023-03157-w","article-title":"Causal associations of Sj\u00f6gren's syndrome with cancers: A two-sample mendelian randomization study","volume":"25","author":"Jia","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01221-y","article-title":"Causal relationships between circulating inflammatory cytokines and diffuse large B cell lymphoma: A bidirectional mendelian randomization study","volume":"23","author":"Yu","year":"2023","journal-title":"Clin Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217441","article-title":"Metabolic reprogramming, Malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer","volume":"611","author":"Hindes","year":"2025","journal-title":"Cancer Lett"},{"key":"B20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12943-025-02523-3","article-title":"Amino acids metabolism: A potential target for cancer treatment","volume":"24","author":"Ren","year":"2025","journal-title":"Mol Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","article-title":"Guidelines for performing mendelian randomization investigations: Update for summer 2023","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"Jama"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: A Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/mcg.0000000000000129","article-title":"Risk and clinical characteristics of lymphoma in Korean patients with inflammatory bowel diseases: A multicenter study","volume":"49","author":"Park","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx040","article-title":"Cancer risk in the early stages of inflammatory bowel disease in Korean patients: A nationwide population-based study","volume":"11","author":"Jung","year":"2017","journal-title":"J Crohns Colitis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.04.001","article-title":"Increasing risk of lymphoma over time in Crohn's disease but not in ulcerative colitis: A Scandinavian cohort study","volume":"21","author":"Olen","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/meg.0000000000002657","article-title":"Concurrence of inflammatory bowel disease with multiple sclerosis or Hodgkin lymphoma","volume":"35","author":"Sonnenberg","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e001037","DOI":"10.1136\/bmjgast-2022-001037","article-title":"Risk of Malignant lymphomas in patients with inflammatory bowel disease: A population-based cohort study","volume":"10","author":"Yu","year":"2023","journal-title":"BMJ Open Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221131501","article-title":"Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival","volume":"31","author":"Kariniemi","year":"2022","journal-title":"Lupus"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02692-8","article-title":"Hematological Malignancies in systemic lupus erythematosus: Clinical characteristics, risk factors, and prognosis-a case-control study","volume":"24","author":"Zhang","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319826672","article-title":"Systemic lupus erythematosus is a risk factor for cancer: A nationwide population-based study in Korea","volume":"28","author":"Bae","year":"2019","journal-title":"Lupus"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez011","article-title":"Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: A nationwide population-based study","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatol (Oxford England)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2017.1384054","article-title":"Increased incidence of cancer in systemic lupus erythematosus: A Finnish cohort study with more than 25 years of follow-up","volume":"47","author":"Tallbacka","year":"2018","journal-title":"Scandinavian J Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key335","article-title":"Temporal relationships between systemic lupus erythematosus and comorbidities","volume":"58","author":"Kuo","year":"2019","journal-title":"Rheumatol (Oxford England)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170179","article-title":"Malignancy in pediatric-onset systemic lupus erythematosus","volume":"44","author":"Bernatsky","year":"2017","journal-title":"J Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2014.05.001","article-title":"Comorbidities of pediatric systemic lupus erythematosus: A 6-year nationwide population-based study","volume":"49","author":"Chan","year":"2016","journal-title":"J Microbiology Immunology Infection = Wei Mian Yu Gan Ran Za Zhi"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000003540","article-title":"Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: A nationwide population-based dynamic cohort study in Taiwan","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2016-000156","article-title":"Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients","volume":"3","author":"Ramsey-Goldman","year":"2016","journal-title":"Lupus Sci Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.3390\/jcm11154272","article-title":"Risk of cancer in connective tissue diseases in Northeastern Italy over 15 years","volume":"11","author":"Treppo","year":"2022","journal-title":"J Clin Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0428-x","article-title":"Comparison of cancer incidence among patients with rheumatic disease: A retrospective cohort study","volume":"16","author":"Chang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: An updated international multi-centre cohort study","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J Autoimmun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313497118","article-title":"Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study","volume":"22","author":"Dey","year":"2013","journal-title":"Lupus"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/art.30483","article-title":"High incidence of potentially virus-induced Malignancies in systemic lupus erythematosus: A long-term followup study in a Danish cohort","volume":"63","author":"Dreyer","year":"2011","journal-title":"Arthritis Rheumatism"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1332-7","article-title":"Incidence of cancer among female patients with systemic lupus erythematosus in Korea","volume":"29","author":"Kang","year":"2010","journal-title":"Clin Rheumatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.08.006","article-title":"Malignancy in systemic lupus erythematosus: A nationwide cohort study in Taiwan","volume":"123","author":"Chen","year":"2010","journal-title":"Am J Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clin Trials"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Res ed)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evidence-Based Ment Health"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.7080","article-title":"Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis","volume":"33","author":"Dybk\u00e6r","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1293","article-title":"Genomic and transcriptomic characterization reveals B-cell hyperactivation and immune evasion in hepatitis B virus-associated diffuse large B-cell lymphoma","volume":"13","author":"Qin","year":"2023","journal-title":"Clin Transl Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ccell.2023.09.004","article-title":"Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial","volume":"41","author":"Zhang","year":"2023","journal-title":"Cancer Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"PNAS"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"EBioMedicine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"PNAS"},{"key":"B59","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Therneau","year":"2000"},{"key":"B60","article-title":"A package for survival analysis in R","author":"Therneau","year":"2024"},{"key":"B61","unstructured":"Survminer: Drawing Survival Curves Using 'Ggplot2'"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PloS One"},{"key":"B64","article-title":"Genome-wide association study of cancer risk in UK biobank","author":"Burrows","year":"2021"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/mph.0000000000000860","article-title":"Thalidomide-induced stroke in a child with thalassemia major","volume":"39","author":"Gunaseelan","year":"2017","journal-title":"J Pediatr Hematology\/Oncology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000991","article-title":"Clonal hematopoiesis and risk for hematologic Malignancy","volume":"136","author":"Warren","year":"2020","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Internal Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.444","article-title":"Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells","volume":"4","author":"Noto","year":"2013","journal-title":"Cell Death Dis"},{"key":"B70","article-title":"Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells","volume":"56","author":"Pizer","year":"1996","journal-title":"Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-07-0389","article-title":"Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells","volume":"67","author":"Beckers","year":"2007","journal-title":"Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1201\/9780429179587-21","article-title":"Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice","volume":"9","author":"Fritz","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2012.07.010","article-title":"Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules","volume":"1820","author":"Kant","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.05.045","article-title":"Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis","volume":"385","author":"Wang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1205995109","article-title":"Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma","volume":"109","author":"Bhatt","year":"2012","journal-title":"PNAS"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"PNAS"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05823.x","article-title":"Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it","volume":"24","author":"Nolan","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-15-0202","article-title":"Drug redeployment to kill leukemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids","volume":"75","author":"Southam","year":"2015","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-011-1122-9","article-title":"L-Leucine induces growth arrest and persistent ERK activation in glioma cells","volume":"43","author":"Takeuchi","year":"2012","journal-title":"Amino Acids"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111850","article-title":"Lysine crotonylation regulates leucine-deprivation-induced autophagy by a 14-3-3epsilon-PPM1B axis","volume":"41","author":"Zheng","year":"2022","journal-title":"Cell Rep"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2423169122","article-title":"Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia","volume":"122","author":"Wang","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"B83","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40364-025-00807-w","article-title":"T cells in cancer: mechanistic insights and therapeutic advances","volume":"13","author":"Pu","year":"2025","journal-title":"biomark Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40164-024-00576-6","article-title":"Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma","volume":"13","author":"Pu","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv271","article-title":"High anabolic potential of essential amino acid mixtures in advanced nonsmall cell lung cancer","volume":"26","author":"Engelen","year":"2015","journal-title":"Ann Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab2674","article-title":"Sestrin2 is a leucine sensor for the mTORC1 pathway","volume":"351","author":"Wolfson","year":"2016","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2087","article-title":"Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway","volume":"351","author":"Saxton","year":"2016","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100720","article-title":"A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma","volume":"3","author":"Fahrmann","year":"2022","journal-title":"Cell Rep Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1934057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:30:15Z","timestamp":1789104615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1934057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":88,"alternative-id":["10.3389\/fimmu.2026.1934057"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1934057","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1934057"}}